Cannabis Investing Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara
Cannabis Investing FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech
Cannabis Investing Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
Cannabis Investing Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility
Cannabis Investing Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares
RUA GOLD Expands High-Grade Intercepts at Depth at Auld Creek: 5.9g/t AuEq over 9m and 48.3g/t AuEq over 1.25m
Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
